Imaging c-Met expression using 18F-labeled binding peptide in human cancer xenografts.
<h4>Objectives</h4>c-Met is a receptor tyrosine kinase shown inappropriate expression and actively involved in progression and metastasis in most types of human cancer. Development of c-Met-targeted imaging and therapeutic agents would be extremely useful. Previous studies reported that...
Saved in:
Similar Items
-
Utilisation of the Innovative [18F]-Labelled Radiotracer [18F]-BIBD-071 Within HR+ Breast Cancer Xenograft Mouse Models
by: Di Fan, et al.
Published: (2025-01-01) -
Micro-PET Imaging of αβ-Integrin Expression with F-Labeled Dimeric RGD Peptide
by: Xiaoyuan Chen, et al.
Published: (2004-04-01) -
Efficacy of MET-targeting CAR T cells against glioblastoma patient-derived xenograft models
by: Anna Qin, et al.
Published: (2025-04-01) -
Preparation and preclinical evaluation of 18F-labeled folate-RGD peptide conjugate for PET imaging of triple-negative breast carcinoma
by: Subhani M. Okarvi, et al.
Published: (2025-05-01) -
Efficient F Labeling of Cysteine-Containing Peptides and Proteins Using Tetrazine–-Cyclooctene Ligation
by: Shuanglong Liu, et al.
Published: (2013-03-01)